Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group. Borggreve SE, et al. Among authors: van der steege g, van tol a. J Clin Endocrinol Metab. 2005 Jul;90(7):4198-204. doi: 10.1210/jc.2005-0182. Epub 2005 Apr 19. J Clin Endocrinol Metab. 2005. PMID: 15840744
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group. Borggreve SE, et al. Among authors: van der steege g, van tol a. J Clin Endocrinol Metab. 2006 Sep;91(9):3382-8. doi: 10.1210/jc.2005-2322. Epub 2006 May 9. J Clin Endocrinol Metab. 2006. PMID: 16684835
Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.
Dullaart RP, Schols JL, van der Steege G, Zelissen PM, Sluiter WJ, van Beek AP. Dullaart RP, et al. Among authors: van beek ap, van der steege g. Clin Endocrinol (Oxf). 2008 Sep;69(3):359-66. doi: 10.1111/j.1365-2265.2008.03196.x. Epub 2008 Jan 23. Clin Endocrinol (Oxf). 2008. PMID: 18221399
Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.
Wijpkema JS, van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, van der Steege G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA. Wijpkema JS, et al. Among authors: van der steege g, van haelst pl. Pharmacogenet Genomics. 2006 May;16(5):331-7. doi: 10.1097/01.fpc.0000205001.07054.fa. Pharmacogenet Genomics. 2006. PMID: 16609364
No association between the Arg201Gly polymorphism of the DCC gene and colorectal cancer.
de Jong MM, te Meerman GJ, van der Graaf WT, de Vries EG, Nolte IM, Mulder MJ, Bruinenberg M, van der Steege G, Schaapveld M, Sijmons RH, Hofstra RM, Kleibeuker JH. de Jong MM, et al. Among authors: van der steege g, van der graaf wt. Dig Liver Dis. 2004 Dec;36(12):821-3. doi: 10.1016/j.dld.2004.07.011. Dig Liver Dis. 2004. PMID: 15646429
Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.
Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, Etuaful S, Raghunathan PL, Whitney EA, Ampadu EO, Asamoa K, Klutse EY, te Meerman GJ, Tappero JW, Ashford DA, van der Steege G. Stienstra Y, et al. Among authors: van der werf ts, van der steege g, van der graaf wt. Genes Immun. 2006 Apr;7(3):185-9. doi: 10.1038/sj.gene.6364281. Genes Immun. 2006. PMID: 16395392
63 results